| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.434 | 5.118 | 15.516 | 8.090 | 21.099 | 5.586 | 15.626 | 17.230 | 11.477 | 8.016 |
| Total Income - EUR | 1.434 | 5.118 | 15.610 | 15.891 | 21.099 | 5.487 | 15.627 | 17.230 | 11.549 | 8.135 |
| Total Expenses - EUR | 398 | 3.648 | 18.666 | 11.413 | 15.173 | 9.048 | 8.628 | 15.095 | 9.888 | 10.993 |
| Gross Profit/Loss - EUR | 1.035 | 1.469 | -3.056 | 4.478 | 5.926 | -3.561 | 6.999 | 2.135 | 1.661 | -2.858 |
| Net Profit/Loss - EUR | 992 | 1.316 | -3.524 | 4.352 | 5.663 | -3.610 | 6.618 | 1.629 | 1.254 | -3.405 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Contrapunct Design Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 89 | 0 | 0 | 0 | 3.047 | 1.934 | 860 | 1.003 | 2.200 | 1.572 |
| Current Assets | 1.300 | 3.049 | 1.193 | 2.613 | 7.155 | 3.288 | 11.885 | 13.455 | 8.759 | 9.843 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 0 | 0 |
| Receivables | 0 | 2.774 | 681 | 69 | 2.529 | 604 | 1.650 | 998 | 863 | 4.581 |
| Cash | 1.300 | 275 | 513 | 2.544 | 4.626 | 2.684 | 10.235 | 12.337 | 7.896 | 5.262 |
| Shareholders Funds | 1.037 | 2.342 | -2.181 | 1.910 | 7.537 | 3.783 | 10.317 | 1.677 | 4.310 | 929 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 352 | 706 | 3.374 | 705 | 2.665 | 1.438 | 2.428 | 12.802 | 6.995 | 10.487 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7111 - 7111" | |||||||||
| CAEN Financial Year |
7111
|
|||||||||
Comments - Contrapunct Design Srl